Products

TRACE4AD™ TRACE4BUS™ TRACE4OC™ Trace4Research™ Trace4DigitalTwin™

TRACE4AD™ is our AI-powered, CE-cleared medical device that provides early-stage, subject-level risk (low risk or high risk) of being affected by or progressing to dementia within 24 months.
Working through data mining and machine-learning classifiers, TRACE4AD™ performs an automatic reading of the subject's brain MRI study, and it automatically identifies features of brain atrophy that begin to occur following neuronal death caused by AD along with mild cognitive impairment typical of the early stages of AD dementia.

TRACE4BUS™ is our AI-based, CE-cleared medical device that uses machine learning to deeply analyze ultrasound images of BC suspicious breast masses of subjects at risks to provide the breast mass BI-RADS category.
TRACE4BUS™ is based on ultrasound image analytics in the breast region, data mining and machine learning classifiers to support physicians in the reporting of ultrasound-detected suspicious breast masses.

TRACE4OC™ is our AI-based, CE-cleared medical device that provides the woman's level of risk of being affected by ovarian cancer.
Our solution leverages the power of machine learning to deeply analyze US images of adnexal ovarian masses of women at risks, with the aim of providing the individual level of risk (very low risk or medium-high risk) of being affected by ovarian cancer.

Trace4Research™ is our proprietary platform based on Artificial Intelligence and Data/Image Analytics.
Through Trace4Research™, highly specialized AI algorithmsare offered as support to non-specialized users in a user-friendly and robust way, following a very simple workflow and usability.

Trace4DigitalTwin™ is our proprietary platform that aggregates patient health information and contextualizes it against population data to support strategic and clinical planning.
Products
Publications
News room
About
Contacts
Customer Care

BOOK A MEETING

DeepTrace at ARM 2024 in Dubai

BEFORE

AFTER

Dubai, UAE - Oct 29, 24

October 29 – 31 , 2024

Dubai World Trade Centre (DWTC), UAE

Come and visit us at booth A03 🚩

📅 From October 29-31, we were part of the 9th Annual Radiology Meeting (ARM) in Dubai.

This has been a great opportunity to showcase our cutting-edge AI technology, designed to support radiologists and improve patient care. Our team is dedicated to advancing healthcare through innovation, making medical imaging more efficient and impactful.

It was a pleasure to see how our solutions were welcomed with enthusiasm!

Let's connect and explore new ways to make a difference together! Looking forward to connecting with industry experts and radiology professionals—use the link below to book a meeting with our dedicated team!

Discover more about DeepTrace solutions

BOOK A MEETING

Products

Legal

Certifications

C.F.-P.IVA 10409380960 | REA MI-2529092
Ethics
Legal Notices
Privacy and Data Protection
Privacy Policy
Cookie Policy

Web Agency Brand039

Products

TRACE4AD™ TRACE4BUS™ TRACE4OC™ Trace4Research™ Trace4DigitalTwin™

TRACE4AD™ is our AI-powered, CE-cleared medical device that provides early-stage, subject-level risk (low risk or high risk) of being affected by or progressing to dementia within 24 months.
Working through data mining and machine-learning classifiers, TRACE4AD™ performs an automatic reading of the subject's brain MRI study, and it automatically identifies features of brain atrophy that begin to occur following neuronal death caused by AD along with mild cognitive impairment typical of the early stages of AD dementia.

TRACE4BUS™ is our AI-based, CE-cleared medical device that uses machine learning to deeply analyze ultrasound images of BC suspicious breast masses of subjects at risks to provide the breast mass BI-RADS category.
TRACE4BUS™ is based on ultrasound image analytics in the breast region, data mining and machine learning classifiers to support physicians in the reporting of ultrasound-detected suspicious breast masses.

TRACE4OC™ is our AI-based, CE-cleared medical device that provides the woman's level of risk of being affected by ovarian cancer.
Our solution leverages the power of machine learning to deeply analyze US images of adnexal ovarian masses of women at risks, with the aim of providing the individual level of risk (very low risk or medium-high risk) of being affected by ovarian cancer.

Trace4Research™ is our proprietary platform based on Artificial Intelligence and Data/Image Analytics.
Through Trace4Research™, highly specialized AI algorithmsare offered as support to non-specialized users in a user-friendly and robust way, following a very simple workflow and usability.

Trace4DigitalTwin™ is our proprietary platform that aggregates patient health information and contextualizes it against population data to support strategic and clinical planning.
Products
Publications
News room
About
Contacts
Customer Care

BOOK A MEETING